BK BLOG

The Use of Intraoperative Ultrasound During a Robotic Caudal Pancreatectomy with Splenic Preservation

A neuroendocrine tumor (NET) is a rare type of tumor that can occur anywhere in the pancreas. Diagnosis and treatment of NETs depend on the type of tumor, its location, whether it produces excess hormones, how aggressive it is and whether it has spread to other parts of the pancreas.¹

Dr. Marcos Belotto, Robotic Surgery Specialist at Celebration Florida Hospital, recently used a bk5000 ultrasound system during a pancreatic surgery case to help him locate a neuroendocrine tumor. Dr. Belotto has a PhD in Surgery from Hospital Sírio Libanês and a Masters of Surgery from Santa Casa de São Paulo.

In this video, US army veteran Jim Brazell describes how bkFusion technology helped his physician manage his prostate cancer disease process. bkFusion is the seamless integration of the bk3000 and bk5000 ultrasound systems with the best visualization and guidance software available. Watch this video with Jim Brazell to learn more about bkFusion from a patient’s perspective.   

The following story is an exerpt from a 2012 article,"Ultrasound Opens New Doors in Robotic Surgery," by Lisa Fratt of Health Imaging.

Since its introduction more than a decade ago, robotic-assisted surgery has stood out as a game-changer. The robotic console provides a robust platform to enable minimally invasive procedures in urologic, cardiothoracic, gynecologic and general surgical procedures. Today, robotic surgery is witnessing an evolution. The most recent surgical ultrasound systems, specifically BK Ultrasound systems for robotic surgery, are ushering in a new level of precision and diagnostic confidence. Intraoperative robotic-assisted ultrasound helps surgeons to perform more complex procedures robotically with potentially improved outcomes, particularly in radical prostatectomy and partial nephrectomy.

Dr. Gavin Quigley is a prominent consultant neurosurgeon based at the Royal Victoria Hospital in Belfast, Northern Ireland, where his team provide care for 1.8 million people. Dr. Quigley has previously worked as an advisor for HIQA (Health Information and Quality Assessment) in the Republic of Ireland and for NICE (National Institute for Clinical Excellence) in the UK, and was appointed as a Consultant Neurosurgeon to the National Neurosurgical Unit in Dublin, Ireland in 2006. He returned to Northern Ireland in 2009, taking up his current position at The Royal Victoria Hospital.

Dr. David Carnovale is the medical director for fertility specialty care at Community Health Network in Indianapolis, Indiana, USA. He is board certified in obstetrics, gynecology, reproductive endocrinology, and infertility, with a specialization in reproductive endocrinology and infertility. One of the procedures he performs regularly is myomectomy, the preferred fibroid treatment for women who are trying to become pregnant.